ClinicalTrials.Veeva

Menu
A

Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Baricitinib
Methotrexate
Ixekizumab
Vedolizumab
Upadacitinib
Mirikizumab
Adalimumab
Iloprost
RO7123520
Secukinumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 28 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Enrolling
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. Th...

Active, not recruiting
Crohn's Disease
Other: Blood Draw
Other: CDPATH™

The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoi...

Active, not recruiting
Joint Diseases
Arthritis
Drug: Peresolimab
Drug: Placebo

The primary objectives of the study are to evaluate the efficacy of BIIB059 (litifilimab) compared with placebo in reducing skin disease activity mea...

Enrolling
Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Drug: BIIB059 (litifilimab)
Drug: Placebo

The COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a multicenter randomized controlled trial designed to evaluate the efficacy a...

Enrolling
Psoriatic Arthritis
Spondylarthritis
Drug: Abatacept
Drug: Baricitinib

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

Trial sponsors

Lilly logo
Takeda logo
Bristol-Myers Squibb (BMS) logo
E
AbbVie logo
Amgen logo
A
AstraZeneca logo
Biogen logo
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems